Ann E. Clarke
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 270 publications
The lupus damage index revision program: Results from the item generation and reduction phases.
Journal: Lupus science & medicine
Published: July 30, 2026
Effectiveness of a Provincial Law to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study.
Journal: International archives of allergy and immunology
Published: February 18, 2026
ERN ReCONNET-SLICC-SLEuro consensus on the therapeutic management of rare systemic lupus erythematosus manifestations (part 2).
Journal: The Lancet. Rheumatology
Published: February 17, 2026
Increased Risk of Intrahepatic Cholestasis of Pregnancy in SLE Women Exposed to Azathioprine.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 11, 2025
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases.
Journal: Arthritis care & research
Published: November 14, 2025
Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registry.
Journal: Advances in rheumatology (London, England)
Published: October 23, 2025
Forgotten costs of systemic lupus erythematosus: estimating indirect healthcare costs in a national prospective observational Canadian lupus cohort.
Journal: Lupus science & medicine
Published: October 17, 2025
Clinical Presentation, Triggers, Comorbidities, and Management of Anaphylaxis in the Elderly: A Cross-Sectional Study.
Journal: International archives of allergy and immunology
Published: July 03, 2025
Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus.
Journal: Journal of clinical epidemiology
Published: June 20, 2025
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step Toward Precision Drug Monitoring.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 22, 2025
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.
Journal: Annals of the rheumatic diseases
Published: May 06, 2025
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry").
Journal: Lupus
Published: April 03, 2025
Last Updated: 09/26/2026